ArticleCancer immunology, immunotherapy : CII2020

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer.

Simer J Bains et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.